Innovations merging artificial intelligence with biomedical sciences are offering transformative solutions across multiple fronts. Chan Zuckerberg Biohub introduced Ultrack and inTRACKtive, novel tools enhancing cell tracking accuracy across biological scales, facilitating insights from embryology to disease. Mount Sinai unveiled MARQO, an AI-driven tool improving cancer tissue analysis efficiency. Separately, an integration of knowledge graphs and AI expedites catalytic pathway design, and a dual-mode LiDAR system enhances sensing capabilities. These advances underscore AI’s growing centrality in biomedical technology development.